Koa Accel

Koa Accel functions as a specialized medical device accelerator, guiding early-stage Class II medical technology companies. It addresses the high failure rate in this sector by deploying expert teams throughout the development lifecycle. The firm accelerates strategic execution, leveraging an extensive network to compress timelines, reduce costs, and limit investor dilution.

Launched around September 2019, the accelerator was founded on the insight that over ninety percent of medical device startups fail due to execution gaps, not innovation. Co-founders, including prominent cardiothoracic surgeon Dr. Francis Duhay, established Koa Accel to provide a structured, expert-driven pathway through complex medical device development.

Koa Accel partners with medical device companies holding promising patents or novel ideas for unmet needs. Its vision transforms these life-saving concepts into commercially viable entities. By integrating expert teams, Koa Accel offers direct support, accelerating product development and market entry for innovators and investors.